Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Creating a flexible budget is essential for effective financial management. Learn the key reasons to implement one and enhance your budgeting.
26,654 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
As AI workloads surge, Celestica could play a pivotal role in data-center hardware. This guide breaks down the busine...
Rivian's R2 rollout marks a new chapter for the EV maker. This guide breaks down whether the stock deserves a place i...
As infrastructure spending gears up, industrial activity is priming the market for a new leg higher. Here are three s...
A 2024 business sale can push couples into IRMAA tiers in 2026. The two-year lookback means higher Medicare costs for...
A rare move by Berkshire Hathaway signals serious confidence in Alphabet’s AI ambitions. This article breaks down wha...
MP Materials is turning a quiet corner in the US defense supply chain, with Pentagon-backed pricing and a plan to bui...
Cardano just caught major regulatory clarity, a development that could reduce some risk for investors. This guide bre...
A tiny misstep over the MAGI line can trigger a full Medicare premium surcharge of $1,062. This report explains who i...
A large 2024 capital gain can trigger IRMAA surcharges, causing Medicare premiums to surge in 2026. Retirees face hun...
A notable fund exit from Sprinklr during a year of rapid AI adoption offers real-world lessons for investors. Here’s ...
A fresh look at IRA activity in 2025-26 shows the $7,500 limit almost nobody hits, with average contributions far bel...